Kiora Pharmaceuticals (KPRX) Financials

$2.55

$0.00 (0.00%)

As on 04-Sep-2026 16:00EDT

Market cap

$11 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.7

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	16.00	--	--	0.01
Cost of Revenue	0.09	0.02	0.38	4.03	0.13	0.23
Gross Profit	-0.09	-0.02	16.00	-4.03	-0.13	-0.23
Operating Expenses	12.78	9.43	11.49	12.59	12.31	14.24
Operating Profit (EBIT)	-12.82	-9.46	4.51	-12.59	-12.31	-14.24
Other Income	--	--	--	--	--	--
Profit before Tax	-12.28	-12.12	5.66	-12.42	-13.70	-13.96
Provision for Tax	-1.29	-1.28	2.07	0.09	-0.11	-0.19
Profit after Tax (Net Income)	-10.99	-10.84	3.59	-12.51	-13.58	-13.77
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	--	-16.39

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	16.86	16.13	25.76	6.11	11.41	14.58
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	4.55	4.50	4.72	5.97	4.00	3.94
Current Liabilities	2.37	3.63	6.01	1.63	3.27	1.61
Total Liabilities	26.15	24.25	36.48	13.71	18.68	20.13

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	2.51	2.50	6.78	8.97	11.00	11.14
Current Assets	21.26	21.75	29.71	4.74	7.68	8.99
Total Assets	26.15	24.25	36.48	13.71	18.68	20.13
Total Debt*	0.33	0.37	0.06	0.11	0.11	0.21
Net Current Assets	18.89	18.12	23.70	3.10	4.41	7.38

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-9.96	8.56	-9.56	-10.43	-10.68
Cash Flow from Investing Activities	--	14.43	-22.66	--	0.01	-0.16
Cash from Financing Activities	--	0.27	15.50	5.97	8.62	17.58
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-2.50	-2.64	1.20	-1.62	-7.56	-1.09
Cash EPS ($)	--	-2.63	1.20	-1.62	-7.54	-1.08
Adjusted Book Value ($)	--	3.93	8.58	0.79	6.35	1.15
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-2.43	2.85	-1.24	-5.80	-0.84
Free Cash Flow per Share ($)	--	-2.45	2.85	-1.24	-5.80	-0.85

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-51.22	22.44	-141.16	-103.29	-109.76
ROE (%)	-66.62	-51.74	22.56	-142.88	-104.54	-113.30
ROA (%)	-35.86	-35.68	14.32	-77.27	-70.00	-77.72
EBIT Margin (%)	--	--	35.51	--	--	-115,734.61
Net Margin (%)	--	--	22.47	--	--	-114,194.25
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	-1.00	--	--	-1.00	--
EBIT Growth (%)	-8.33	-312.94	145.77	9.32	1.92	-85.95
Net Profit Growth (%)	8.31	-401.42	128.73	7.88	1.36	-100.69
EPS Growth (%)	23.79	-3.20	1.74	0.79	-5.95	0.98
Book Value Growth (%)	-50.81	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-0.75	2.75	-0.32	-0.45	-1.39
Price / Book Value	0.66	0.50	0.38	0.66	0.54	1.31
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-1.03	0.72	-2.95	-0.14	-0.02	-0.83
Close Price ($)	2.63	1.97	3.30	4.70	30.87	543.60
High Price ($)	3.29	4.18	8.98	76.64	644.40	2,826.00
Low Price ($)	1.76	1.76	3.00	4.16	20.88	288.07
Market Cap ($ Cr)	11.28	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.02	0.00	0.02	0.01	0.01
Short term debt to equity ratio	0.01	0.01	0.00	0.01	0.01	0.01
Current Ratio	8.97	5.99	4.94	2.90	2.35	5.59
Quick Ratio	8.97	--	--	2.90	--	--
Interest Coverage	-614.22	-606.08	264.91	-1,115.02	-1,591.82	-2,037.14

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	3.76	--	--	4,391.41
Asset Turnover	--	--	0.64	--	--	0.00
Receivable days	--	--	30.26	--	--	9,397.56
Inventory Days	--	--	0.00	0.00	--	--
Payable days	--	10,867.93	299.24	55.08	1,592.71	478.42
Cash Conversion Cycle	--	--	-268.98	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.